Quest Diagnostics Incorporated
DGX
$195.23
-$3.38-1.70%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.78% | 13.74% | 12.58% | 9.38% | 6.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.78% | 13.74% | 12.58% | 9.38% | 6.70% |
| Cost of Revenue | 11.52% | 12.94% | 12.26% | 9.36% | 6.68% |
| Gross Profit | 12.30% | 15.37% | 13.24% | 9.41% | 6.74% |
| SG&A Expenses | 10.92% | 12.49% | 12.81% | 8.45% | 7.18% |
| Depreciation & Amortization | 21.26% | 31.62% | 31.25% | 23.42% | 17.59% |
| Other Operating Expenses | 100.00% | 300.00% | -- | 200.00% | 0.00% |
| Total Operating Expenses | 11.56% | 13.19% | 12.66% | 9.40% | 6.93% |
| Operating Income | 13.13% | 17.09% | 12.13% | 9.25% | 5.35% |
| Income Before Tax | 13.90% | 16.92% | 13.62% | 5.75% | 3.29% |
| Income Tax Expenses | 15.02% | 22.86% | 16.53% | 6.83% | 10.08% |
| Earnings from Continuing Operations | 13.57% | 15.28% | 12.81% | 5.45% | 1.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -8.00% | -16.33% | -8.00% | 3.77% | 7.41% |
| Net Income | 13.89% | 15.22% | 13.10% | 6.03% | 1.99% |
| EBIT | 13.13% | 17.09% | 12.13% | 9.25% | 5.35% |
| EBITDA | 13.77% | 17.81% | 14.07% | 10.79% | 7.06% |
| EPS Basic | 13.81% | 14.87% | 13.00% | 6.43% | 2.56% |
| Normalized Basic EPS | 12.39% | 11.71% | 7.78% | 4.50% | 2.45% |
| EPS Diluted | 13.57% | 15.74% | 13.90% | 7.63% | 3.81% |
| Normalized Diluted EPS | 12.42% | 11.26% | 7.57% | 4.54% | 2.70% |
| Average Basic Shares Outstanding | 0.22% | 0.00% | 0.00% | -0.45% | -0.67% |
| Average Diluted Shares Outstanding | 0.22% | 0.44% | 0.22% | -0.44% | -0.88% |
| Dividend Per Share | 6.67% | 6.42% | 6.16% | 5.90% | 5.63% |
| Payout Ratio | -0.06% | -0.08% | -0.06% | -0.01% | 0.03% |